Clinical Trial Update: Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated atrasentan for safety and efficacy in men with hormone-naive prostate cancer showing early biochemical failure. The study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Atrasentan (atrasentan)

Snippet

Sponsor: Abbott | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED